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Editors: Anton N. Sidawy and Bruce A. PerlerFive-year results of thoracic endovascular aortic repair
with the Zenith TX2
Jon S. Matsumura, Germano Melissano, Richard P. Cambria,
Michael D. Dake, Shraddha Mehta, Lars G. Svensson, Randy
D. Moore
Background: This trial evaluated thoracic endovascular
aortic repair (TEVAR) compared with open surgical repair of
descending thoracic aortic aneurysms and large ulcers at 42
international sites. Whereas several studies demonstrate
early safety and utility advantages with TEVAR, longer fol-
low-up is important because of concerns about durability of
TEVAR.
Methods: This prospective, nonrandomized study enrolled
160 TEVAR patients treated with the Cook Zenith TX2 and
70 open surgical repair patients.
Results: Although follow-up was limited, 5-year mortality
rate was similar at 37% for both groups. Aneurysm-related
mortality rate was 5.9% with TEVAR compared with 12%
with open surgical repair (P = .11). There were no ruptures
of the treated aneurysms in either group or open con-
versions in the TEVAR group. Predeﬁned severe morbidity
occurred at a signiﬁcantly lower rate in TEVAR (21%) com-
pared with open surgical repair (39%; P < .001). Aneurysm
growth was seen by core laboratory in 5.9% of patients and
endoleak in 5.7% of patients. Secondary intervention rates
were similar between TEVAR (8%) and open surgical repair
(12%; P = .49) patients.
Conclusions: Five-year results indicate similar all-cause
mortality and aneurysm-related mortality with TEVAR
compared with open repair. There was a persistent reduc-
tion of severe complications with TEVAR. Reinterventions
occurred with similar frequency. TEVAR with the TX2 is a
safe and effective alternative to open surgical repair for the
treatment of anatomically suitable descending thoracic
aortic aneurysms and ulcers.A clinical decision model for selecting the most
appropriate therapy for uncomplicated chronic dissections
of the descending aorta
Wouter, Hogendoorn, M.G. Myriam Hunink, Felix J.V.
Schlösser, Frans L. Moll, Bauer E. Sumpio, Bart E. Muhs
Objective: The optimal treatment for patients with
uncomplicated chronic Stanford type B aortic dissections*Full articles available online at www.jvascsurg.org
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http://dx.doi.org/10.1016/S1078-5884(14)00302-5(chTBADs) is still matter of debate. The purpose of this
study was to design a decision tool to guide the surgeon in
determining the preferred treatment option.
Methods: A Markov decision-analysis model compared
chTBAD patients treated with initial open surgical repair
(OSR), thoracic endovascular aortic repair (TEVAR), and
optimal medical therapy (OMT), followed during follow-up
by OSR (OMT-OSR) or TEVAR (OMT-TEVAR), if indicated.
Procedural risks, aortic growth and rupture rates, outcomes,
and quality of life values were derived from the best
available evidence in the literature. A chTBAD treatment
strategy decision tool was developed, including the four key
variables of age, sex, surgical risk, and maximum initial
aortic diameter. Primary outcome was quality-adjusted life-
years (QALYs).
Results: For the reference patient cohort, 55-year-old men
with chTBAD with a maximum aortic diameter of 5.0 cm,
medium risk for surgery, and a threshold for surgery of 6.0 cm
during follow-up, OSR yielded higher QALYs, with 10.06 QALYs
(95% credibility interval [CI], 9.52-10.56 QALYs) vs 9.92 QALYs
(95% CI, 9.23-10.58 QALYs) after TEVAR and 9.64 QALYs (95%
CI, 9.38-9.88 QALYs) and 9.40 QALYs (95% CI, 9.11-9.69 QALYs)
for OMT-OSR and OMT-TEVAR. The difference between OSR
and OMT-OSR was 0.42 QALYs (95% CI, 0.01-0.81 QALYs) and
between TEVAR and OMT-TEVAR was 0.52 QALYs (95% CI,
0.04-0.68 QALYs). This showed that intervention is preferred
over OMT. A change of the four variables resulted in a change
of preferred treatment. In general, OSR was the preferred
treatment in younger patients with a larger aortic diameter
and in low-risk patients. TEVAR was preferred in elderly
patients with large aortic diameter and if the aortic diameter
threshold for repair decreased. OMTwas the optimal therapy
in high-risk patients, elderly patients, or in patients with small
aortic diameters.
Conclusions: This decision-analysis model shows that there
is no “one-size-ﬁts-all” treatment for uncomplicated
chTBADs. For the reference patient cohort, intervention is
preferred over OMT. Age is the most important deciding
factor, followed by initial aortic diameter. Immediate OSR is
the preferred treatment option in younger patients with a
large initial aortic diameter and in low-risk patients.
Immediate TEVAR is preferred in elderly patients with a
large initial aortic diameter and in patients with a lower
threshold for OSR. OMT should be considered in high-risk
patients, in patients with small initial aortic diameters, and
in patients aged >80 years, unless their initial aortic
diameter is >5.5 cm. However, the differences in some
patient groups are clinically insigniﬁcant, allowing a major
role for patient preferences and hospital-speciﬁc consid-
erations. This clinical decision model may guide chTBAD
treatment.
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isolated aortic arch aneurysm
Vikram Sood, Himanshu J. Patel, David M. Williams,
Narasimham L. Dasika, Bo Yang, G. Michael Deeb
Objective: Repair of isolated aortic arch aneurysms (non-
traumatic) by either open (OAR) or endovascular (TEVAR)
methods is associated with need for hypothermic circu-
latory arrest, complex debranching procedures, or use of
marginal proximal landing zones. This study evaluates out-
comes for treatment of this cohort.
Methods: Of 2153 patients undergoing arch repair (1993-
2013), 137 (mean age, 60 years) were treated with isolated
arch resection for nontraumatic aneurysms. Treatment was
by open (n = 93), hybrid (n = 11), or TEVAR (n = 33)
methods, with the last two approaches reserved for poor
OAR candidates. Treatment was predominantly for saccular
(n = 53) or fusiform (n = 30) aneurysms or dissection (n =
15). Rupture was present in 15%. Prior aortic repair was
performed in the ascending (n = 30), arch (n = 40),
descending (n = 24), or abdominal (n = 9) aorta. Propensity
score adjustment was performed for multivariable analysis
to account for baseline differences in patient groups as well
as treatment selection bias.
Results: Early mortality was seen in nine patients (7%).
Morbidity included stroke (n = 9), paraplegia (n = 1), and need
for dialysis (n = 5) or tracheostomy (n = 10). A composite
outcome of death and strokewas independently predicted by
advancing age (P = .055) and performance of a hybrid pro-
cedure (P = .012). The 15-year survival was 59%, with late
mortality predicted by increasing age, presence of peripheral
vascular disease, and perioperative stroke (all P < .05). The
10-year freedom from aortic rupture or reintervention was
75% and was higher after OAR (2-year OAR, 94% vs TEVAR or
hybrid, 78%; P = .018). After propensity-adjusted Cox
regression analysis, both prior abdominal aortic aneur-
ysmectomy (P = .017) and an endovascular or hybrid proce-
dure (P = .001) independently predicted late aortic rupture or
need for reintervention.
Conclusions: Isolated arch repair remains a high-risk pro-
cedure occurring frequently in the reoperative setting.
Despite being performed in a higher risk group, endovas-
cular strategies yielded similar outcomes but with an
increased risk for aorta-related complications. These data
support ongoing efforts to develop branched endografts
speciﬁcally tailored for arch disease to potentially reduce
morbidity related to currently available approaches.Low rates of complications for carotid artery stenting are
associated with a high clinician volume of carotid artery
stenting and aortic endografting but not with a high
volume of percutaneous coronary interventions
J. Gregory Modrall, Jayer Chung, Melissa L. Kirkwood, M.
Shadman Baig, Shirling X. Tsai, Carlos H. Timaran, R. James
Valentine, Eric B. RoseroObjective: Prior studies have demonstrated improved clinical
outcomes for surgeons with a high-volume experience with
certain open vascular operations. A high-volume experience
with carotid artery stenting (CAS) improves clinical out-
comes. Moreover, it is not known whether experience with
other endovascular procedures, including percutaneous
coronary interventions (PCIs), is an adequate substitute for
experience with CAS. The goal of this study was to quantify
the effect of increasing clinician volume of CAS, endovascular
aneurysm repair (EVAR), and thoracic endovascular aortic
aneurysm repair (TEVAR), and PCI on the outcomes for CAS.
Methods: The Nationwide Inpatient Sample was analyzed
to identify patients undergoing CAS for the years 2005 to
2009. Clinicians were stratiﬁed into tertiles of low-volume,
medium-volume, and high-volume groups by annual vol-
ume of CAS, EVAR/TEVAR, and PCI. Multiple logistic
regression analyses were used to examine the relationship
between clinician volume and a composite outcome of the
in-hospital stroke and death rate after CAS.
Results: Between 2005 and 2009, 56,374 elective CAS
procedures were performed nationwide, with a crude in-
hospital stroke and death rate of 3.22%. A median of nine
CAS procedures (interquartile range, 3-20) were performed
annually per clinician. As expected, stroke and death rates
for CAS decreased with increasing volume of CAS performed
by a clinician (low-volume vs medium-volume vs high-vol-
ume: 4.43% vs 2.89% vs 2.27%; P = .0001). Similar patterns
were noted between clinicians' volume of EVAR/TEVAR
(low-volume vs medium-volume vs high-volume: 4.58% vs
3.18% vs 2.16%; P = .0023). In contrast, increasing PCI
volume was not associated with decreased stroke and death
rates after CAS (low-volume vs medium-volume vs high-
volume: 2.99% vs 3.18% vs 3.55%; P = .35). After adjusting
for patient and hospital characteristics, clinician volume of
CAS (odds ratio [OR], 0.84; 95% conﬁdence interval [CI],
0.74-0.94; P = .003) and EVAR/TEVAR (OR, 0.85; 95% CI,
0.75-0.97; P = .020) remained signiﬁcant predictors of
stroke and death after CAS, whereas increasing clinician
volume of PCI was associated with signiﬁcantly increasing
likelihood of stroke or death after CAS (OR, 1.025; 95% CI,
1.004-1.047; P = .019).
Conclusions: The stroke and death rate for CAS to treat
carotid stenosis is inversely affected by the number of CAS
and EVAR/TEVAR procedures performed by a clinician. In
contrast, a high-volume experience with PCI is not asso-
ciated with improved outcomes after CAS.Evaluation of Medicare claims data to ascertain peripheral
vascular events in the Women's Health Initiative
Matthew W. Mell, Mary Pettinger, Lori Proulx-Burns, Susan
R. Heckbert, Matthew A. Allison, Michael H. Criqui, Mark A.
Hlatky, Dale R. Burwen
Objective: Capturing long-term outcomes from large clinical
databases by use of claims data is a potential strategy for
112 Abstractsimproving efﬁciency while reducing study costs. We sought
to compare the use of Medicare data with data from the
Women's Health Initiative (WHI) to determine peripheral
vascular events, as deﬁned by the WHI study design.
Methods: We studied participants from the WHI with both
adjudicated outcomes and links to Medicare enrollment and
utilization data through 2007. Outcomes of interest inclu-
ded hospitalizations for treatment of abdominal aortic
aneurysm (AAA), lower extremity peripheral artery disease
(LE PAD), and carotid artery stenosis (CAS). Events deter-
mined by WHI adjudication were compared with events
deﬁned by coding algorithms using diagnosis and procedure
codes from Medicare data with a pilot data set and then
validated with a test data set. We assessed agreement by a
k statistic and evaluated reasons for disagreement.
Results: In the pilot set, records from 50,511 participants
were analyzed. Agreement between the Centers for Medi-
care and Medicaid Services and WHI for admissions with a
diagnosis but no treatment procedures for vascular con-
ditions was poor (k, 0.02-0.18). On the basis of WHI outcome
data collection, vascular treatment procedures occurred in
29 participants for AAA, 204 for LE PAD events, and 281 for
CAS. Medicare hospital claims recorded 41 treatments for
AAA, 255 for LE PAD, and 317 for CAS. For participants with a
Centers for Medicare and Medicaid Services-captured vas-
cular procedure and a record adjudicated byWHI, k values for
treatment procedures were 0.81 for AAA, 0.77 for PAD, and
0.93 for CAS. For vascular procedures identiﬁed by WHI but
not byMedicare hospital data (n = 82), 55%were captured by
Medicare physician claims. Conversely, for treatments iden-
tiﬁed by Medicare hospital data but not captured by WHI
adjudication (n = 57), 74% had physician claims consistent
with the procedure. Fifteen participants with AAA or LE PAD
procedures in hospital claims had medical records available
for review, and nine of these had deﬁnitive documentation of
procedures that were not captured by the WHI adjudication
process. Estimated positive predictive value ofMedicare data
was 91% to 94% for AAA, 92% to 95% for LE PAD, and 94% to
99% for CAS. Available test set data (n = 50,253) yielded
generally similar results with k of 0.77 for AAA, 0.79 for LE
PAD, and 0.94 for CAS.
Conclusions: Medicare data appear useful for identifying
vascular treatment procedures for WHI participants. Medi-
care hospital claims identify more procedures than WHI
does, with high positive predictive value, but also may not
capture some procedures identiﬁed in WHI.Outcomes reported by the Vascular Quality Initiative and
the National Surgical Quality Improvement Program are
not comparable
Francesco A. Aiello, Bing Shue, Nisha Kini, Amy Rosen, Louis
Messina, William Robinson, Philimon Gona, Andres
Schanzer
Objective: The Vascular Quality Initiative (VQI) and National
Surgical Quality Improvement Program (NSQIP) haveemerged as the primary vascular surgery quality measure-
ment tools with the purpose of evaluating perioperative
outcomes and assessing hospital and physician quality. VQI
uses self-reporting to capture all index vascular procedures
during the inpatient period. NSQIP employs nurse abstrac-
tors to capture a sample of procedures and covers 30-day
events. We hypothesize that patients undergoing lower
extremity bypass (LEB) will exhibit high concordance for
preoperative variables and low concordance for post-
operative variables between these data sets.
Methods: All patients undergoing LEB for peripheral arterial
disease at the University of Massachusetts captured in both
VQI and NSQIP databases were reviewed (2007-2012).
Concordance between categorical variables was assessed by
k correlation coefﬁcient. All postoperative variables were
compared during equivalent inpatient stay. Events between
discharge and 30 days postoperatively were tabulated with
use of the NSQIP data set.
Results: We identiﬁed 240 patients undergoing LEB cap-
tured in both VQI and NSQIP. Comparison of this identical
patient cohort between VQI and NSQIP revealed a mod-
erate to strong agreement for most preoperative variables
except for congestive heart failure (k = 0.14) and hyper-
tension (k = 0.35), which showed poor agreement. Con-
cordance for inpatient postoperative variables was high
for mortality (k = 1.0) and myocardial infarction (k = 0.86)
but moderate for pulmonary complications (k = 0.57) and
poor for unplanned return to the operating room (k =
0.41), wound infection (k =  0.01), and change in renal
function (k =  0.01). A majority of postoperative events
(71%) occurred between discharge and 30 days post-
operatively, with a signiﬁcantly higher incidence of wound
infections in the outpatient setting (4.2% vs 95.8%; P <
.0001).
Conclusions: VQI and NSQIP demonstrate substantial con-
cordance for most preoperative variables and poor con-
cordance for most postoperative variables, even at identical
collection periods. This discordance is a result of differences
in data collection methods and variable deﬁnitions. On the
basis of these ﬁndings, VQI and NSQIP data sets cannot be
used to directly compare risk-adjusted patient outcomes
between institutions.Molecular diagnosis in vascular Ehlers-Danlos syndrome
predicts pattern of arterial involvement and outcomes
Sherene Shalhub, James H. Black, Alana C. Cecchi, Zhi Xu,
Ben F. Griswold, Hazim J. Saﬁ, Dianna M. Milewicz, Nazli B.
McDonnell
Objective: The management of arterial pathology in indi-
viduals with vascular Ehlers-Danlos syndrome (vEDS)
remains a challenge. Here we describe the correlation
between COL3A1 gene mutation type and the clinical
phenotype in individuals with vEDS.
Methods: Individuals with conﬁrmed molecular diagnoses of
vEDS were enrolled in a multi-institutional natural history
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family histories, arterial pathology (aneurysm, dissection,
and rupture), operative details, and autopsy reports. Indi-
viduals were classiﬁed into two cohorts by the type of
COL3A1mutations and their effect on the amount of normal
collagen produced: those with mutations that lead to mini-
mal (MIN) production (10%-15%) of normal type III collagen
and those with haploinsufﬁciency (HI) mutations that lead to
production of 50% of the normal type III collagen.
Results: A cohort of 68 individuals (72%) from 56 families
had arterial pathology (44% male) with 13% HI. The HI
group was older at the time of their ﬁrst vascular event
(mean, 42 [range, 26-58] years vs 33 [range, 8-62] years; P =
.016) and had a higher incidence of aortic pathology than
the MIN group (56% vs 21%; P = .025). Visceral arterial
pathology was seen in 43 arteries in 23 individuals in the
MIN group vs only one artery in ﬁve individuals in the HI
group. Emergency surgical procedures were more likely to
be undertaken when vEDS diagnosis was not known (81% vs
41%; P = .005), and 81% of these procedures were open
surgical repair compared with 19% endovascular repairs (P =
.019). Open and endovascular repairs were equally used in
the elective setting. Postoperative complications were
highest when the diagnosis of vEDS was not known (62% vs
14%; P < .001) and when procedures were undertaken in an
emergency setting (5% vs 55% P < .001). Mortality due to
arterial complications was 0% in the HI cohort and 21% in
the MIN cohort (P = .132).
Conclusions: Arterial pathology in vEDS individuals is rela-
ted to the underlying COL3A1 mutation type. The arterial
pathology in individuals with HI mutations occurs at later
ages with a higher incidence of aortic disease compared
with other COL3A1 mutation types. Molecular diagnosis is
recommended because diagnosis conﬁrmation, appropriate
surveillance, and prophylactic interventions in an elective
setting improve surgical outcomes.Vitamin D deﬁciency is associated with mortality and
adverse vascular access outcomes in patients with end-
stage renal disease
Joy P. Walker, Jade S. Hiramoto, Warren J. Gasper, Philip
Auyang, Michael S. Conte, Joseph H. Rapp, David H. Lovett,
Christopher D. OwensBackground: Plasma 25 hydroxycholecalciferol (vitamin D)
deﬁciency has been associated with adverse cardiovascular
outcomes in epidemiologic studies. Chronic kidney disease
is associated with loss of 1a-hydroxylase and consequently
vitamin D deﬁciency. We hypothesized that vitamin D
deﬁciency was associated with increased mortality and
increased vascular access failure in patients undergoing
permanent vascular access for end-stage renal disease.
Methods: This retrospective cohort study analyzed 128
patients undergoing permanent vascular access surgery
between 2003 and 2012 for whom concurrent plasma
vitamin D levels were also available. Levels were considered
deﬁcient at <20 ng/mL. Multivariable analysis was used to
determine the association between vitamin D and mortality
and vascular access outcomes.
Results: The mean age was 66.7 years, 96.8% were male,
32.0% were African American, and 60.9% had diabetes
mellitus. In the entire cohort, 55.5% were vitamin D-deﬁ-
cient, despite similar rates of repletion among the vitamin
D-deﬁcient and nondeﬁcient groups. During a median fol-
low-up of 2.73 years, there were 40 deaths (31%). Vitamin
D-deﬁcient patients tended to be younger (P = .01) and to
have higher total cholesterol (P = .001) and lower albumin
(P = .017) and calcium (P = .007) levels. Despite their
younger age, mortality was signiﬁcantly higher (P = .026)
and vascular access failure was increased (P = .008) in the
vitamin D-deﬁcient group. Multivariate logistic regression
analysis found vitamin D deﬁciency (odds ratio [OR], 3.64;
95% conﬁdence interval [CI], 1.12-11.79; P = .031), hemo-
dialysis through a central catheter (OR, 3.08; 95% CI, 1.04-
9.12; P = .042), coronary artery disease (OR, 3.08; 95% CI,
1.06-8.94; P = .039), increased age (OR, 1.09; 95% CI, 1.03-
1.15; P = .001), and albumin (OR, 0.27; 95% CI, 0.09-0.83;
P = .023) remained independent predictors of mortality.
Vitamin D deﬁciency (hazard ratio [HR], 2.34; 95% CI, 1.17-
4.71; P = .02), a synthetic graft (HR, 3.50; 95% CI, 1.38-8.89;
P = .009), and hyperlipidemia (HR, 0.42; 95% CI, 0.22-0.81;
P = .01) were independent predictors of vascular access
failure in a Cox proportional hazard model.
Conclusions: Vitamin D deﬁciency is highly prevalent in
patients undergoing vascular access procedures. Patients
who are deﬁcient in vitamin D have worse survival and
worse vascular access outcomes. Further study is warranted
to assess whether aggressive vitamin D repletion will
improve outcomes in this population.
